Newsroom
Sorted by: Latest
-
Hytera Introduces PNC660 450MHz: New Device Certified for Power and Energy Mission-Critical Networks
BARCELONA, Spain--(BUSINESS WIRE)--Hytera unveiled the PNC660 450MHz MCX Smart Device – an advanced mission-critical terminal for private 450MHz LTE and 5G networks at MWC Barcelona....
-
H2O.ai and CTC Global Singapore Have Partnered Together To Democratize Agentic AI Across APAC
SINGAPORE--(BUSINESS WIRE)--H2O.ai, the leading open-source AI platform company, and CTC Global Singapore, a trusted technology integrator across Asia Pacific, today announced a collaboration to accelerate enterprise AI adoption across the region. The collaboration was formalized at a signing ceremony in Singapore, marking a milestone in delivering trusted, production-grade Agentic AI designed to support users in secure and regulated environments. This partnership directly addresses the evolvin...
-
Liberty Energy Inc. Announces Pricing of Upsized $475.0 Million Convertible Senior Notes Offering
DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) (“Liberty”) today announced the pricing of, and that it has agreed to sell, $475.0 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “Notes”) in a private offering (the “Notes Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Liberty also granted the initial purchasers an option to purch...
-
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) today announced that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), for the indication of “gastrointestinal stromal tumor that has progressed following cancer chemotherapy.” This application is based on the results of the INVICTUS study, a global Phase 3 clinical...
-
Anaergia Reports Positive Adjusted EBITDA1 and Strong Revenue Growth in Fiscal 2025
BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia (TSX: ANRG; OTCQX:ANRGF) reports positive Adjusted EBITDA, 61% revenue growth and Revenue Backlog up 149% in fiscal 2025....
-
Taco Bueno Turns Up the Heat with New Fuego Menu Line
DALLAS--(BUSINESS WIRE)--Taco Bueno launches Fuego Fuel: a limited-time spicy lineup with bold Tex-Mex flavors....
-
While Private Equity Firms Abandon Homeowners Overnight, Evolve Construction Is Planting Roots in Kansas and Missouri
KANSAS CITY, Mo.--(BUSINESS WIRE)--Evolve Construction operates across 35+ markets in the U.S. with HAAG & IICRC certification, proprietary AI, and a 100% satisfaction guarantee....
-
Coast to Coast! Dickey’s Barbecue Pit Solidifies Major Restaurant Deals in Q1 to Bring Legit. Texas. Barbecue. to New Communities Across the U.S.
DALLAS--(BUSINESS WIRE)--Coast to Coast! Dickey’s Barbecue Pit Solidifies Major Restaurant Deals in Q1 to Bring Legit. Texas. Barbecue. to New Communities Across the U.S....
-
GTJAI (1788.HK) Achieved Record-High Revenue in 2025 with Profitability Making a Leapfrog Improvement
HONG KONG--(BUSINESS WIRE)--In 2025, Guotai Junan International Holdings Limited (“GTJAI” or the “Company”, the “Group”, stock code: 1788.HK), a company of Guotai Haitong Group, adhered to a prudent and pragmatic business philosophy, maintained the bottom line of risk control, focused on its core businesses and achieved comprehensive high-quality growth across all business segments with remarkable operating results. During the year, the Group’s revenue hit a record high, increased significantly...
-
国泰君安国际(1788.HK)2025年收入创历史新高 盈利水平跨越式提升
香港--(BUSINESS WIRE)--(美国商业资讯)-- 2025年,国泰海通集团下属公司国泰君安国际控股有限公司(“国泰君安国际”、“集团”或“公司”,股份代号:1788.HK)秉持稳健务实的经营理念,坚守风险底线,聚焦核心主业,推动各业务实现全面高质量增长,经营成果丰硕。年内,集团收入创历史新高,同比大幅上升41%至62.30亿港元,普通股股东应占溢利同比大幅跃升287%至13.45亿港元,盈利规模实现跨越式提升。董事会建议宣派截至2025年12月31日年度之末期股息每股0.02港元,连同已派发的中期股息每股0.05港元,全年股息合共每股0.07港元,派息比率50%,每股股息增长119%。 厚积薄发,财富管理2.0拉开帷幕 2025年,集团全面推进财富管理2.0战略落地,坚持“客户需求为核心、定制化服务为特色、数字化能力为支撑”的发展方向,完成“平台+产品”综合性升级。年内,OTC产品交易增长迅猛,成为佣金收入主力来源之一,其中结构性票据、OTC期权佣金均同比跃升超过100%,产品交易量、客户参与人数较2024年分别增长超50%,成为集团财富管理业务高质量发展的核心支柱。同时...